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Questions. Angiotensin II (Ang II) modulates vascular smooth muscle cell (VSMCs) 
contractility and the expression of potassium (K+) channels. Among them, voltage gated K+ 
channels belonging to Kv7 family modulate arterial contractility and mediate the responses to 
several endogenous vasorelaxants. In particular, Kv7.4 protein is down-regulated in several 
arterial beds in different models of hypertension. In this study we evaluated the effects of Ang 
II on vascular Kv7.4 expression and function. 
 
Methods. Whole mesenteric artery (MA), as well as isolated VSMCs from Wistar rats were 
incubated with 100nM Ang II. Subcellular localisation of Kv7.4 subunits was assessed by 
immunofluorescence experiments. RNA and protein levels were measured by quantitative 
PCR and western blot. Functional effects were evaluated by wire myography. Proximity 
Ligation Assays were performed to measure protein:protein interactions. 
 
Results. Ang II reduced Kv7.4 localisation at the plasma membrane in VSMCs, and 
decreased protein expression in MA without a concomitant reduction of mRNA levels. In 
addition, Ang II impaired the vasorelaxation produced by the Kv7.4 activator ML213 in pre-
contracted MA. Proteasome-inhibitor MG132 prevented Ang II-induced reduction of Kv7.4 
protein levels and function. Ang II decreased the number of interactions of Kv7.4 with the 
chaperone protein HSP90, and increased the interaction with the E3 ubiquitin ligase CHIP. 
Inhibition of HSP90 with 17-AAG reduced Kv7.4 protein levels and increased its interaction 
with CHIP. 
 
Conclusions. Ang II alters Kv7.4 protein stability by decreasing its interaction with HSP90.  
This determines Kv7.4 degradation via the proteasome, possibly by an increased activity of 
CHIP.  
